Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination

Core Insights - The article discusses Becton, Dickinson and Company (BDX) following their Q4 earnings report for 2025, highlighting that the stock was trading at approximately $177 per share at that time [1]. Company Overview - Becton, Dickinson and Company is a significant player in the healthcare sector, focusing on medical technology and devices [1]. Analyst Background - The author has a master's degree in Analytics and a bachelor's degree in Accounting, with over 10 years of experience in the investment field, starting as an analyst and advancing to a management role [1].